Challenges and Opportunities in the Design of Liver-on-Chip Microdevices

Annual Review of Biomedical Engineering, 2019, 21: 219-239. Challenges and Opportunities in the Design of Liver-on-Chip Microdevices Authors: Avner Ehrlich, Daniel Duche, Gladys Ouedraogo, and Yaakov Nahmias
https://doi.org/10.1146/annurev-bioeng-060418-052305

Abstract

The liver is the central hub of xenobiotic metabolism and consequently the organ most prone to cosmetic- and drug-induced toxicity. Failure to detect liver toxicity or to assess compound clearance during product development is a major cause of postmarketing product withdrawal, with disastrous clinical and financial consequences. While small animals are still the preferred model in drug development, the recent ban on animal use in the European Union created a pressing need to develop precise and efficient tools to detect human liver toxicity during cosmetic development. This article includes a brief review of liver development, organization, and function and focuses on the state of the art of long-term cell culture, including hepatocyte cell sources, heterotypic cell–cell interactions, oxygen demands, and culture medium formulation. Finally, the article reviews emerging liver-on-chip devices and discusses the advantages and pitfalls of individual designs. The goal of this review is to provide a framework to design liver-on-chip devices and criteria with which to evaluate this emerging technology.